With a market capitalization (market cap) of $1.05B — a measure of how much the company is worth — Faeth Therapeutics, Inc. is the 2558th most valuable company in Healthcare as of September 4, 2026. Shares trade at $40.55, up +4.32% on the day.
of 2,579
price ÷ annual EPS
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company's lead program, PIKTOR, is an investigational all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. [28, 70]
Visit websiteAs of September 4, 2026, Faeth Therapeutics, Inc. (FTH) is worth $1.04B — this is its market capitalization, the total value of all its outstanding shares.
Faeth Therapeutics, Inc.’s market cap is $1.04B, which ranks it #2558 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
Faeth Therapeutics, Inc. (FTH) shares trade at $40.42, up 3.65% on the day, as of September 4, 2026.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2025